期刊
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
卷 16, 期 10, 页码 1411-1418出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2010.04.005
关键词
Aplastic anemia; Older age; Human leukocyte antigen-matched bone marrow transplantation; Cyclophosphamide/antithymocyte globulin conditioning
资金
- National Institutes of Health, Bethesda, MD, USA [HL36444, CA15704, AI067770]
- Regione Piemonte, Italy
- NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036444] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067770] Funding Source: NIH RePORTER
Patients with severe aplastic anemia (SAA) over 40 years of age are often not offered treatment with hematopoietic cell transplantation (HCT) because of concerns about treatment-related morbidity or mortality. To evaluate this risk, we analyzed outcomes after allogeneic HCT from HLA-identical sibling donors for all older patients with SAA at our center since 1988. The 23 consecutive patients ranged in age from 40 to 68 years. The conditioning regimen was cyclophosphamide (200 mg/kg) and horse antithymocyte globulin. Methotrexate and cyclosporine were given for postgrafting immunosuppression. The cumulative incidences of grades II, III, and IV acute graft-versus-host-disease were 30%, 4%, and 0%, respectively; that for chronic GVHD was 26%. With a median follow-up of 9.1 years, overall survival was 65%. Documented infections within 1 month before HCT were significantly associated with risk of early treatment-related mortality (P < .001). The median time to discontinuation of posttransplant immunosuppression was 6.2 (range: 5.9-92.0) months. Three patients developed superficial basal cell carcinoma between 5.5 and 15 years after HCT. Our data favor a practice of extending HLA-identical sibling HCT for treatment of SAA in patients older than 40 years of age who are without significant medical comorbidities. Biol Blood Marrow Transplant 16: 1411-1418 (2010) (c) 2010 American Society for Blood and Marrow Transplantation
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据